SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-23-050238
Filing Date
2023-10-30
Accepted
2023-10-30 16:53:52
Documents
1
Period of Report
2023-10-18

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 4841
  Complete submission text file 0001140361-23-050238.txt   6101
Mailing Address
Business Address
KAYNE RICHARD A (Reporting) CIK: 0000884413 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36183 | Film No.: 231361030

Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Issuer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)